MAANF yields 666.67% · JNJ yields 2.13%● Live data
📍 MAANF pulled ahead of the other in Year 1
Combined, MAANF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MAANF + JNJ for your $10,000?
Maanshan Iron & Steel Company Limited, together with its subsidiaries, manufactures and sells iron and steel products, and related by-products in Mainland China, Hong Kong, and internationally. It offers steel plates, including hot and cold-rolled thin plates, galvanized plates, coil-coating plates, and medium plates; section steel products comprising H-shaped steel and medium-shaped steel; high-speed wire rod and hot-rolled reinforcing steel products; and rain wheels and wheel rims. It also engages in the production and distribution of ferrous metallurgy, screw threaded steels, round and section steels, angle and deformed steels, wires, and rods; sales, imports, and exports of iron ore, iron ore fines, and scrap steel; metallurgy and extended processing of ferrous metals; production and sales of coke and coke chemical products and energy; production and distribution of metallic products; design, research and development, manufacturing, maintenance, and sales of rail wheels, axles, wheel sets, bogies, and other rail equipment; trading of steel products and pig iron; and investment and trading businesses. The company was founded in 1953 and is headquartered in Maanshan, the People's Republic of China.
Full MAANF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.